New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
13:25 EDTMDCO, MDCO, MDCOLeerink's biotech analysts hold an analyst/industry conference call
Biotech Analyst Schwartz, along with MEDACorp Specialist Cahrles Whitcomb, MD, discuss the prospects for The Medicines Co's Cangrelor in Percutaneous Coronary Intervention (PCI)/Acute Coronary Syndrome (ACS) on an Analyst/Industry conference call to be held on February 7 at 2 pm.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
07:07 EDTMDCOThe Medicines Co. reports FDA approves new formulation of MINOCIN
Subscribe for More Information
07:02 EDTMDCOEagle Pharmaceuticals price target raised to $75 from $55 at Piper Jaffray
Subscribe for More Information
April 15, 2015
17:49 EDTMDCOThe Medicines Co. up 7% after FDA panel backs approval of cangrelor
Subscribe for More Information
17:18 EDTMDCOThe Medicines Co. confirms FDA Advisory Committee backs approval of cangrelor
Subscribe for More Information
15:37 EDTMDCOFDA panel votes in favor of approval for cangrelor
Subscribe for More Information
07:57 EDTMDCOThe FDA Cardiovascular & Renal Drugs Advisory Committee to hold a meeting
The Committee discusses The Medicines Company's New Drug Application (NDA) 204958 Cangrelor injection for proposed indication of reduction of thrombotic cardiovascular events at a meeting being held at FDA Silver Spring, Maryland offices on April 15 at 8 am. Webcast Link
07:01 EDTMDCOThe Medicines Co. stock trading halted today
Subscribe for More Information
April 13, 2015
11:13 EDTMDCOFDA panel briefing docs look positive for Medicines Co., says Leerink
Subscribe for More Information
10:15 EDTMDCOHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use